ERGO (Entia Biosciences) EPS (Basic): $-0.05 (TTM As of Dec. 2016)


What is Entia Biosciences EPS (Basic)?

Entia Biosciences ERGO EPS (Basic) is $-0.05 as of Dec. 2016.

Entia Biosciences's basic earnings per share (Basic EPS) for the three months ended in Dec. 2016 was $-0.02. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2016 was $-0.05.

Entia Biosciences's EPS (Diluted) for the three months ended in Dec. 2016 was $-0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2016 was $-0.05.

Entia Biosciences's EPS without NRI for the three months ended in Dec. 2016 was $-0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2016 was -0.05.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Entia Biosciences  (OTCPK:ERGO) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Entia Biosciences EPS (Basic) Related Terms

Entia Biosciences EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Entia Biosciences's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entia Biosciences EPS (Basic) Chart

Entia Biosciences Annual Data
Trend Jul07 Jul08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.18 -0.42 -0.24 -0.09 -0.05

Entia Biosciences Quarterly Data
Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.01 -0.01 -0.01 -0.02

Entia Biosciences EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Entia Biosciences's Basic EPS for the fiscal year that ended in Dec. 2016 is calculated as

Basic EPS (A: Dec. 2016 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1.396-0)/28.137
=-0.05

Entia Biosciences's Basic EPS for the quarter that ended in Dec. 2016 is calculated as

Basic EPS (Q: Dec. 2016 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.433-0)/28.146
=-0.02

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $-0.05 mean?
Entia Biosciences (ERGO) has a EPS (Basic) of $-0.05 as of Dec. 2016. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Entia Biosciences and its competitors.
Is Entia Biosciences' EPS (Basic) too high?
Entia Biosciences' current EPS (Basic) is $-0.05.
How does Entia Biosciences' EPS (Basic) compare to OBMP and NSPX?
Entia Biosciences' EPS (Basic) of $-0.05 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Entia Biosciences and its competitors. Entia Biosciences's current EPS (Basic) is $-0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entia Biosciences stock overvalued right now?
Entia Biosciences (ERGO) has a current EPS (Basic) of $-0.05. The current EPS (Basic) is $-0.05. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Entia Biosciences (ERGO), the current EPS (Basic) is $-0.05 as of Dec. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entia Biosciences Business Description

Address 13565 South West Tualatin-Sherwood Road, Suite 800, Sherwood, OR, USA, 97140
Entia Biosciences Inc operates as a biotechnology company, is engaged in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products, principally in the United States of America. It market nutraceutical products under the name GROH and SANO directly to the consumers online. It currently offers natural organic nutraceutical mushroom dietary supplement products, ImmuSANO, GlucoSANO, and GROH, which has been designed to nutritionally support hair follicles and nail beds. It derives its revenue from the sale of its GROH line and mushroom-based nutraceutical dietary supplement products and functional ingredients.